Cited by 221Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchPeripheral Neuropathies and Disorders

Diagnosis and management of motor neurone disease

Open access
McDermott, Christopher J, Shaw, Pamela J·2008·BMJ

Abstract

Motor neurone disease is a devastating illness which leads to progressive paralysis and eventual death. We will discuss the presentation of motor neurone disease in primary care and update non-specialists on progress with regards to life prolonging interventions, better control of disease symptoms, and an increased understanding of disease mechanisms. Motor neurone disease is rare but patients often are aware of it, so this review should help non-specialists reassure patients in whom it is unlikely to be the diagnosis.

Integrity signals

Registry

Crossref · 10.1136/bmj.39493.511759.be

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Approximately 20% of people living with ALS experience initial changes in the brainstem (bulbar) region, resulting in dysarthria.

    “Approximately 20% of plwALS experience initial changes in the brainstem (bulbar) region of the brain, resulting in dysarthria (McDermott and Shaw, 2008).”

    From Dysarthria and other-initiated repair in everyday conversation (2020) · cites this paper as McDermott and Shaw, 2008

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McDermott, C. J., & Shaw, P. J.
Affiliations
University of Sheffield (GB)
Corresponding author
McDermott, Christopher J
Venue
BMJ
Publisher
BMJ
Published
2008-03-20
Volume
336
Issue
7645
Pages
658-662
ISSN
  • 1756-1833 (ISSN-L)
  • 0959-8138
OpenAlex
W1993915028
Cited by
220
References
28
Citations by year
2026: 8 · 2025: 12 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 11 · 2020: 35 · 2019: 14 · 2018: 8 · 2017: 15 · 2016: 11 · 2015: 16 · 2014: 9 · 2013: 12 · 2012: 9
FWCI
4.92
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
motor neuron disease, diagnosis, management, primary care, symptom management, disease mechanisms, progressive paralysis, patient reassurance
MeSH terms
Antioxidants, Diagnosis, Differential, Humans, Physician-Patient Relations, Respiratory Therapy, Motor Neuron Disease, Neuroprotective Agents, Riluzole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review